Twice-Yearly Dosing of Inclisiran Provides Significant LDL-C Lowering
Twice-yearly dosing with inclisiran sodium resulted in significant lowering of low-density lipoprotein cholesterol.
AHA 2019
Benefits of Sacubitril/Valsartan Appear to Be Greater in Certain HFpEF Subgroups
Treatment with sacubitril/valsartan provides greater benefits in certain patients with HFpEF, according to analyses from the phase 3 PARAGON-HF trial.
Empagliflozin Reduces HF Hospitalization Risk Compared With Other Antidiabetic Agents
Treatment with empagliflozin, a SGLT2 inhibitor, was associated with reduced risk of hospitalization for heart failure.
Epidemiology and Treatment of Opioid-Related Cardiac Arrest
Opioid overdose victims who suffer cardiac arrest are distinctly different from other cardiac arrest patients, yet they may be more likely than others to survive long enough to be admitted to a hospital.
E-Cigarettes Associated With Vascular Dysfunction and Adverse Lipid Profile
Similar to results among people who smoked traditional cigarettes, e-cigarette smoking negatively effects heart disease risk factors, namely, cholesterol, triglycerides and glucose levels, and decreases blood flow in the heart.
Youths With Cardiac Arrhythmia Likely to Have Depression, Anxiety, ADHD
Higher rates of depression, anxiety, and attention-deficit/hyperactivity disorder have been linked to congenital heart disease; however, data thus far have been limited for younger patients with cardiac arrhythmia.
Set of CVD Risk Factors May Be Associated With Increased Risk for Cancer
The presence of key cardiovascular disease risk factors may be associated with an increased risk of developing cancer.
Intensive BP Control May Increase Residual Lifespan in Patients at High Risk for CVD
Tight, intensive blood pressure control was found to improve residual survival length in middle aged and older individuals at risk for cardiovascular disease.
Bariatric Surgery Improves Cerebrovascular Outcomes in Patients With Obesity
Obese people who undergo weight-reduction surgery live longer than obese people who do not have surgery.
Approximately 1 in 3 Patients With ASCVD Not Receiving Flu Shot
About one in three individuals with ASCVD did not receive an influenza vaccination in the past year.
Want to read more?
Please login or register first to view this content.
Next post in AHA 2019
